Wex Medical Limited is an integrated neuro-bioscience company focused on the development and communication of innovative drug products, primarily for pain management and drug product manufacturing and sales. The company headquartered in Canada with subsidiaries in Beijing and Nanning. It is currently listed on the Toronto Stock Exchange with the trading symbol: WXI.
Its lead compound, Tetrodotoxin (TTX), a sodium channel blocker, is the platform for the Company's development of a portfolio of proprietary products in the field of analgesia, drug addiction withdrawal treatment, and local anaesthesia.
The company currently has 13 patents or patent applications covering its manufacturing technology, therapeutic applications, and addressing pharmaceutical formulations. Patents have been granted or applied for in 63 countries. Moreover, the company has registered Drug Master Files (DMF) with Canada and the United States for its pharmaceutical grade TTX substance.

My Sourcing

Wex Medical Limited

Company Information

Company Award/ Qualification

Contact